Literature DB >> 9797105

Heterogeneity of reproductive tract abnormalities in men with absence of the vas deferens: role of cystic fibrosis transmembrane conductance regulator gene mutations.

K Jarvi1, S McCallum, J Zielenski, P Durie, E Tullis, M Wilchanski, M Margolis, M Asch, B Ginzburg, S Martin, M B Buckspan, L C Tsui.   

Abstract

OBJECTIVE: To determine if the types of reproductive tract abnormalities linked to absence of the vas deferens varies with the cystic fibrosis transmembrane conductance regulator (CFTR) genotype.
DESIGN: Prospective data gathering.
SETTING: University infertility clinic. PATIENT(S): Forty-six infertile men with absence of the scrotal vas deferens and no signs of cystic fibrosis. INTERVENTION(S): All had blood taken for CFTR gene analysis, 33 had scrotal ultrasounds, and 25 had transrectal ultrasounds. MAIN OUTCOME MEASURE(S): The frequency of testicular, seminal vesicle, and ampullae of the vas deferens malformations was compared between subgroups of men with two, one, or no CFTR gene mutations. RESULT(S): None (0 of 21) of the men with at least one CFTR gene mutations had normal ampullae of the vas or seminal vesicles bilaterally. Two (50%) of 4 men with no CFTR gene mutations had normal ampullae of the vas deferens bilaterally, and 50% had normal bilateral seminal vesicles (statistically significantly different). There was no correlation between testicular malformations and CFTR genotype. CONCLUSION(S): This study indicates that the severity of the malformations in the testis is unrelated to the CFTR genotype, whereas the frequency and severity of wolffian duct malformations are related directly to the CFTR genotype.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9797105     DOI: 10.1016/s0015-0282(98)00247-7

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  11 in total

Review 1.  The cystic fibrosis transmembrane regulator gene and male infertility.

Authors:  C Quinzii; C Castellani
Journal:  J Endocrinol Invest       Date:  2000-11       Impact factor: 4.256

2.  The workup and management of azoospermic males.

Authors:  Keith Jarvi; Kirk Lo; Ethan Grober; Victor Mak; Anthony Fischer; John Grantmyre; Armand Zini; Peter Chan; Genevieve Patry; Victor Chow; Trustin Domes
Journal:  Can Urol Assoc J       Date:  2015 Jul-Aug       Impact factor: 1.862

Review 3.  Sonographic findings of the genital tract in boys with cystic fibrosis.

Authors:  Valeria Rathaus; Miriam Werner; Enrique Freud; Meir Mei-Zahav; Huda Mussaffi; Hanna Blau
Journal:  Pediatr Radiol       Date:  2005-12-02

4.  Mutations in the cystic fibrosis transmembrane regulator gene and in vivo transepithelial potentials.

Authors:  Michael Wilschanski; Annie Dupuis; Lynda Ellis; Keith Jarvi; Julian Zielenski; Elizabeth Tullis; Sheelagh Martin; Mary Corey; Lap-Chee Tsui; Peter Durie
Journal:  Am J Respir Crit Care Med       Date:  2006-07-13       Impact factor: 21.405

5.  Urogenital abnormalities in male children with cystic fibrosis.

Authors:  H Blau; E Freud; H Mussaffi; M Werner; O Konen; V Rathaus
Journal:  Arch Dis Child       Date:  2002-08       Impact factor: 3.791

6.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

7.  Bilateral carcinoma in situ of the testis and cystic fibrosis transmembrane conductance regulator (CFTR) mutation in an azoospermic patient with late-onset 21beta-hydroxylase deficiency.

Authors:  L Foppiani; M Baffico; G Lando; C Cappi; P De Cassan; M C Patrosso; A Vitali; S Penco; M Giusti; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

Review 8.  Is intracytoplasmic sperm injection safe? Current status and future concerns.

Authors:  D M Nudell; L I Lipshultz
Journal:  Curr Urol Rep       Date:  2001-12       Impact factor: 3.092

9.  Cystic fibrosis transmembrane conductance regulator-related male infertility: Relevance of genetic testing & counselling in Indian population.

Authors:  Avinash Gaikwad; Shagufta Khan; Seema Kadam; Rupin Shah; Vijay Kulkarni; Rangaswamy Kumaraswamy; Kaushiki Kadam; Vikas Dighe; Rahul Gajbhiye
Journal:  Indian J Med Res       Date:  2020-12       Impact factor: 2.375

10.  Exon 10 CFTR gene mutation in male infertility.

Authors:  Zohreh Hojati; Somaye Heidari; Majid Motovali-Bashi
Journal:  Iran J Reprod Med       Date:  2012-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.